Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2009
10/13/2009US7601493 Methods and apparatus for screening and detecting multiple genetic mutations
10/13/2009US7601492 detecting a polynucleotide-polypeptide interaction domain in a genome of an organism, involves immunoprecipitating polynucleotides linked to a polypeptide; identify various functional DNA elements embedded in the human genome
10/13/2009US7601491 Pretreatment method for extraction of nucleic acid from biological samples and kits therefor
10/13/2009US7601490 Development of influenza A antivirals
10/13/2009US7601489 Reducing or inhibiting infection of cells with a retrotransposable element ; side effect reduction
10/13/2009US7601350 Antibodies that bind M. tuberculosis polypeptides
10/13/2009US7601349 GIPs, a family of polypeptides with transcription factor activity that interact with Goodpasture antigen binding protein
10/13/2009US7601344 Von Hippel-Lindau (VHL) gene in cancer cells which express neuropeptide Y, neurofilament, and microtubule associated protein 2; plasmids; Parkinson's disease, amyotrophic lateral sclerosis, Huntington's chorea, Alzheimer's disease, brain infarction, spinal cord injury, brain contusion or malignant tumor
10/13/2009US7601343 An isolated RNA-pulsed antigen presenting cell comprising tumor specific RNA; stimulation of cytotoxic T-lymphocyte proliferation ex vivo or in vivo for adoptive immunotherapy; anticarcinogenic agents; antitumor agents; bactericides; viricides
10/13/2009US7601270 Microfabricated elastomeric valve and pump systems
10/13/2009CA2367925C Self assembling arrays
10/13/2009CA2337559C Method and reagent for determination of cholesterol in remnant-like particles
10/13/2009CA2334935C Screening for blood coagulation defects using metal ions
10/13/2009CA2222650C Tnf-.alpha. converting enzyme
10/13/2009CA2222513C Agents binding specifically to biotin for detecting damaged nucleic acid bases
10/08/2009WO2009124296A2 Method of enhancing enzyme activity
10/08/2009WO2009124255A2 Methods for transcript analysis
10/08/2009WO2009124254A1 Nucleotide analogs
10/08/2009WO2009124251A1 Gene signatures for the prognosis of cancer
10/08/2009WO2009124210A1 Methods, compositions, uses, and kits useful for vitamin d deficiency and related disorders
10/08/2009WO2009124090A1 Compositions and methods for treating and diagnosing asthma
10/08/2009WO2009124085A1 Improvement of sequence data by reduction of noise due to carry-over primer
10/08/2009WO2009123996A2 Hybridization quantitation method for modified micro-rna and -dna based oligonucleotides
10/08/2009WO2009123990A1 Cancer risk biomarker
10/08/2009WO2009123903A1 Hemostatic microspheres
10/08/2009WO2009123889A1 Device for optimizing sperm quality
10/08/2009WO2009123767A1 Scanning system and method for imaging and sequencing
10/08/2009WO2009123748A1 Method of obtaining antibodies of interest and nucleotides encoding same
10/08/2009WO2009123737A2 Advanced detection of sepsis
10/08/2009WO2009123736A2 Process and method for monitoring gastrointestinal microbiota
10/08/2009WO2009123730A1 Methods for diagnosis and prognosis of pulmonary hypertension
10/08/2009WO2009123667A2 Methods and compositions including diagnostic kits for the detection in samples of methicillin-resistant staphylococcus aureus
10/08/2009WO2009123642A1 Nucleotide analogs
10/08/2009WO2009123592A1 Device and method for analysis of samples with depletion of analyte content
10/08/2009WO2009123494A1 Method for simultaneously detecting a plurality of rna sequences in a biological sample
10/08/2009WO2009123373A1 New skin sampling kit which stores nucleic acids in stable status, genetic test methods by using the kit and their practical application
10/08/2009WO2009123367A1 Method for determination of dna methylation
10/08/2009WO2009123347A1 Virus titration method
10/08/2009WO2009123255A1 Method and apparatus for selection of aptamer, and sensing method using the aptamer
10/08/2009WO2009123216A1 Novel dna capable of being amplified by pcr with high selectivity and high efficiency
10/08/2009WO2009122892A1 Kit and method for determining whether or not unmethylated cytosine conversion treatment is appropriately performed and method for analyzing methylated dna using the same
10/08/2009WO2009122448A2 Susceptibility variants for peripheral arterial disease and abdominal aortic aneurysm
10/08/2009WO2009122422A1 Probes and primers for detection of hepatitis b virus and a method thereof
10/08/2009WO2009122388A1 A method for the detection of group b streptococcus (gbs) (streptococcus agalactiae) in mammals
10/08/2009WO2009122201A1 Method for detection of herpesvirus in a test sample
10/08/2009WO2009122159A2 Biosensor for analyte detection
10/08/2009WO2009122069A1 Method for the real-time detection of microorganisms in a liquid culture medium by agglutination
10/08/2009WO2009122067A1 Method for real-time detection of microorganisms in a liquid culture medium using cellular lysis
10/08/2009WO2009122053A1 Method for in vitro diagnosis or prognosis of testicular cancer
10/08/2009WO2009122052A1 Method for the in vitro diagnosis or prognosis of testicular cancer
10/08/2009WO2009122051A2 Method, process, and kit for cancer diagnosis, prognosis, and aftercare
10/08/2009WO2009121924A1 Metastatic markers
10/08/2009WO2009121897A1 Diagnosis of hereditary spastic paraplegias (hsp) by identification of a mutation in the zfyve26 gene or protein
10/08/2009WO2009121878A2 In vitro diagnostic method for the diagnosis of somatic and ovarian cancers
10/08/2009WO2009121727A1 Detection and enumeration of microorganisms
10/08/2009WO2009121726A1 Detection and enumeration of microorganisms
10/08/2009WO2009121550A1 Methods and assays for capture of nucleic acids
10/08/2009WO2009121243A2 Hepatitis b variants with reduced sensitivity to therapeutic compounds, their detection and uses thereof
10/08/2009WO2009121212A1 A detect system and method of the microoranism cell forms
10/08/2009WO2009121137A1 Method for imaging directional cell migration
10/08/2009WO2009121091A1 Mapping method for polyploid subjects
10/08/2009WO2009102438A3 Aptamer inhibitors of osteopontin and methods of use thereof
10/08/2009WO2009102349A9 Sensors for measuring contaminants
10/08/2009WO2009099905A3 Molecular signatures and biomarkers associated with melanoma and methods of use thereof
10/08/2009WO2009094647A3 P53 biomarkers
10/08/2009WO2009089512A3 Immune system modeling devices and methods
10/08/2009WO2003083074A9 Novel gene targets and ligands that bind thereto for treatment and diagnosis of colon carcinomas
10/08/2009US20090255012 Sweet pepper hybrid 9942595
10/08/2009US20090255011 Sweet pepper hybrid 9954288
10/08/2009US20090255010 Tomato hybrid bs 01031842
10/08/2009US20090255007 system for production of stable, genetically transformed maize cells; methods of achieving stable transformation include tissue culture methods and media, methods for bombardment of recipient cells with desired transforming DNA, and methods of growing fertile plants from transformed cells
10/08/2009US20090255004 G-Protein Coupled Receptor and Uses Therefor
10/08/2009US20090255003 Diagnostic and therapeutic target SLC39A11 proteins for neurodegenerative diseases
10/08/2009US20090255001 Parkinson's Disease-Related Gene GRK5 and Uses Thereof
10/08/2009US20090254388 Urotensin 2 and its Receptor as Candidate Genes for Beef Marbling Score, Ribeye Area and Fatty Acid Composition
10/08/2009US20090253952 Methods and Compositions for Improved Fertilization and Embryonic Survival
10/08/2009US20090253896 Selective substrates for matrix metalloproteinases
10/08/2009US20090253779 Expression of Rbap48 in Memory and Aging and Methods Related Thereto
10/08/2009US20090253777 Methods of diagnosing and treating hyperproliferative disorders
10/08/2009US20090253775 Compositions and Methods for Therapy and Diagnosis of Cancer and Cancer Metastasis
10/08/2009US20090253771 Inhibition of gliotoxin
10/08/2009US20090253770 Target gene mimitin of myc
10/08/2009US20090253769 Inhibitors of mammalian hdac 11 useful for treating hdac 11 mediated disorders
10/08/2009US20090253731 Method of identifying therapeutic agents
10/08/2009US20090253670 nicotinic receptor modulators such as N-[3-(1H-pyrrol-1-yl)benzyl]-4-[(trifluoromethyl)thio]benzamide, useful for treating and preventing a condition or disorder affecting cognition, neurodegeneration and schizophrenia
10/08/2009US20090253643 Equol level regulator
10/08/2009US20090253617 Diagnosis and treatment of attentional disorders
10/08/2009US20090253591 Methods for identifying neuripotent cells
10/08/2009US20090253589 Method for Testing Active Compounds
10/08/2009US20090253588 Screening assays for identifying differentiation-inducing agents and production of differentiated cells for cell therapy
10/08/2009US20090253587 Integrated Biosensor and Simulation System for Diagnosis and Therapy
10/08/2009US20090253584 Method for the determination of the DNA methylation level of a CPG position in identical cells within a tissue sample
10/08/2009US20090253581 High Throughput Detection of Molecular Markers Based on AFLP and High Throughput Sequencing
10/08/2009US20090253211 Semiconductor nanocrystal probes for biological applications and process for making and using such probes
10/08/2009US20090253162 Method and apparatus for analyzing skin and hair
10/08/2009US20090253161 Fluorescent prochelators for cellular iron detection
10/08/2009US20090253160 Novel method of predicting pig litter size by evaluating semen
10/08/2009US20090253159 Ion channel assay methods
10/08/2009US20090253158 Lipoxygenase Enzyme Assay
10/08/2009US20090253157 Method of directed differentiation of porcine embryonic stem cells and using the said cells in drug screening